c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation.

Zhao, Peiyan; Sun, Xiaodan; Li, Hui; Liu, Yan; Cui, Yanan; Tian, Lin; Cheng, Ying

Zhao, Peiyan; Sun, Xiaodan; Li, Hui; Liu, Yan; Cui, Yanan; Tian, Lin; Cheng, Ying.

Afiliación

Zhao P; Postdoctoral Research Workstation, Jilin Cancer Hospital, Changchun 130012, China.
Sun X; Postdoctoral Research Workstation, Jilin Cancer Hospital, Changchun 130012, China.
Li H; Medical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun 130012, China.
Liu Y; Medical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun 130012, China.
Cui Y; Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun 130012, China.
Tian L; Medical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun 130012, China.
Cheng Y; Medical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun 130012, China.

Cancers (Basel) ; 14(3)2022 Jan 18.

Article en En | MEDLINE | ID: mdl-35158730

Palabras clave

HDAC3; NKG2DL; SCLC; c-Myc; histone deacetylation; innate immune response

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google